Complex multifactorial nature of significant hyperbilirubinemia in neonates

Pediatrics

Volumn 124, Issue 5, 2009, Pages

  Watchko, Jon F ^a   Lin, Zhili ^b   Clark, Reese H ^b   Kelleher, Amy S ^b   Whit Walker, M ^b   Spitzer, Alan R ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b PEDIATRIX MEDICAL GROUP   (United States)

Author keywords

Genetics; Hyperbilirubinemia; Neonates

Indexed keywords

BILIRUBIN; BLOOD GROUP ANTIBODY; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUCURONOSYLTRANSFERASE 1A1; ORGANIC ANION TRANSPORTER 2;

AFRICAN AMERICAN; ARTICLE; ASIAN; BILIRUBIN BLOOD LEVEL; BLOOD GROUP ABO SYSTEM; BLOOD GROUP O; CIRCULATION; CLINICAL EVALUATION; CLINICAL TRIAL; CONTROLLED STUDY; ETHNICITY; EXCHANGE BLOOD TRANSFUSION; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENE MUTATION; GENETIC VARIABILITY; GESTATIONAL AGE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MATERNAL BLOOD; MATERNAL DIABETES MELLITUS; MULTICENTER STUDY; NEWBORN; NEWBORN JAUNDICE; PHOTOTHERAPY; PRIORITY JOURNAL; RISK FACTOR;

FEMALE; GENE FREQUENCY; GLUCOSEPHOSPHATE DEHYDROGENASE; GLUCURONOSYLTRANSFERASE; HUMANS; HYPERBILIRUBINEMIA, NEONATAL; INFANT, NEWBORN; MALE; MUTATION; ORGANIC ANION TRANSPORTERS; POLYMORPHISM, GENETIC;

EID: 70350507255     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2009-0460     Document Type: Article

References (57)

1. Watchko JF. Indirect hyperbilirubinemia in the neonate. In: Maisels MJ, Watchko JF, eds. Neonatal Jaundice. Amsterdam, Netherlands: Harwood Academic Publishers; 2000:51-66
2. American Academy of Pediatrics, Subcommittee on Neonatal Hyperbilirubinemia. Neonatal jaundice and kernicterus. Pediatrics. 2001;108(3):763-765
3. Bhutani VK, Johnson LH, Maisels MJ, et al. Kernicterus: epidemiologic strategies for its prevention through systems-based approaches. J Perinatol. 2004;24(10):650-662
4. American Academy of Pediatrics, Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 2004;114(1):297-316
5. Watchko JF, Daood MJ, Biniwale M. Understanding neonatal hyperbilirubinemia in the era of genomics. Semin Neonatol. 2002;7(2):143-152 (Pubitemid 34983065)
6. Kaplan M, Hammerman C, Maisels MJ. Bilirubin genetics for the nongeneticist: hereditary defects of neonatal bilirubin conjugation. Pediatrics. 2003;111(4):886-893 (Pubitemid 36402918)
7. Kaplan M, Hammerman C. Bilirubin and the genome: the hereditary basis of unconjugated neonatal hyperbilirubinemia. Curr Pharmacogenomics. 2005;3(1):21-42 (Pubitemid 40352697)
8. Kaplan M, Herschel M, Hammerman C, Hoyer HD, Heller GZ, Stevenson DK. Neonatal hyperbilirubinemia in African American males: the importance of glucose-6-phosphate dehydrogenase deficiency. J Pediatr. 2006;149(1):83-88 (Pubitemid 44081921)
9. Huang CS, Hung KL, Huang MJ, Li YC, Liu TH, Tang TK. Neonatal jaundice and molecular mutations in glucose-6-phosphate dehydrogenase deficient newborn infants. Am J Hematol. 1996;51(1):19-25
10. Valaes T. Neonatal jaundice in glucose-6-phosphate dehydrogenase deficiency. In: Maisels MJ, Watchko JF, eds. Neonatal Jaundice. Amsterdam, Netherlands: Harwood Academic Publishers; 2000:67-72
11. Clarke DJ, Moghrabi N, Monaghan G, et al. Genetic defects of the UDP-glucuronosyltransferase-1 (UGT1) gene that cause familial non-haemolytic unconjugated hyperbilirubinemias. Clin Chim Acta. 1997;266(1):63-74 (Pubitemid 27511713)
12. Kaplan M. Genetic interaction in the pathogenesis of neonatal hyperbilirubinemia: Gilbert's syndrome and glucose-6-phosphate dehydrogenase deficiency. J Perinatol. 2001;21(suppl 1):S30-S34 (Pubitemid 34055869)
13. Huang MJ, Kua KE, Teng HC, Tang KS, Weng HW, Huang CS. Risk factors for severe hyperbilirubinemia in neonates. Pediatr Res. 2004;56(5):682-689 (Pubitemid 39403390)
14. Huang CS. Molecular genetics of unconjugated hyperbilirubinemia in Taiwanese. J Biomed Sci. 2005;12(3):445-450
15. Kaplan M, Renbaum P, Vreman HJ, et al. (TA)n UGT 1A1 promoter polymorphism: a crucial factor in the pathophysiology of jaundice in G-6-PD deficient neonates. Pediatr Res. 2007;61(6):727-731 (Pubitemid 46800283)
16. Kaplan M, Renbaum P, Levy-Lahad E, Hammerman C, Lahad A, Beutler E. Gilbert's syndrome and glucose-6-phosphate dehydrogenase deficiency: a dose dependent genetic interaction crucial to neonatal hyperbilirubinemia. Proc Natl Acad Sci U S A. 1997;94(22):12128-12132 (Pubitemid 27467854)
17. Cui Y, Konig J, Leier I, Bucholz U, Keppler D. Hepatic uptake of bilirubin and its conjugates by the human organic anion transporter SLC21A6. J Biol Chem. 2001;276(13):9626-9630 (Pubitemid 37391856)
18. Cui Y, König J, Nies AT, et al. Detection of the human organic anion transporters SLC21A6 (OATP2) and SLC21A8 (OATP8) in liver and hepatocellular carcinoma. Lab Invest. 2003;83(4):527-538 (Pubitemid 36457707)
19. Lin Z, Fontaine J, Watchko JF. Coexpression of gene polymorphisms involved in bilirubin production and metabolism. Pediatrics. 2008;122(1). Available at: www.pediatrics.org/cgi/content/full/122/1/e156
20. Huang CS, Chang PF, Huang MJ, Chen ES, Chen WC. Glucose-6-phosphate dehydrogenase deficiency, the UDP-glucuronosyl transferase 1A1 gene and neonatal hyperbilirubinemia. Gastroenterology. 2002;123(1):127-133 (Pubitemid 34747533)
21. Bhutani VK, Johnson L, Sivieri EM. Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns. Pediatrics. 1999;103(1):6-14 (Pubitemid 29281921)
22. Nanjundaswamy S, Petrova A, Mehta R, Bernstein W, Hegyi T. The accuracy of transcutaneous measurements in neonates: a correlation study. Biol Neonate. 2004;85(1):21-25 (Pubitemid 38437643)
23. Lin Z, Fontaine JM, Freer DE, Naylor EW. Alternative DNA-based newborn screening for glucose-6-phosphate dehydrogenase deficiency. Mol Genet Metab. 2005;86(1-2):212-219 (Pubitemid 41412178)
24. nTAA polymorphisms best predicts Gilbert's syndrome in Italian pediatric patients. Genet Test. 2006;10(2):121-125
25. Kaplan M, Hammerman C. Gilbert syndrome in the newborn. Isr Med Assoc J. 2007;9(10):765-766
26. Bosma PJ, Chowdhury JR, Bakker C, et al. The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome. N Engl J Med. 1995;333(18):1171-1175
27. Beutler E, Gelbart T, Demina A. Racial variability in the UDP-glucuronosyl-transferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism? Proc Natl Acad Sci U S A. 1998;95(14):8170-8174 (Pubitemid 28326085)
28. Huang CS, Luo GA, Huang MJ, Yu SC, Yang SS. Variations of the bilirubin uridineglucuronosyl transferase 1A1 gene in healthy Taiwanese. Pharmacogenetics. 2000;10(6):539-544
29. Marzolini C, Tirona RG, Kim RB. Pharmacogenomics of the OATP and OAT families. Pharmacogenomics. 2004;5(3):273-282
30. Michalski C, Cui Y, Nies AT, et al. A naturally occurring mutation in the SLC21A6 gene causing impaired membrane localization of the hepatocyte uptake transporter. J Biol Chem. 2002;277(45):43058-43063 (Pubitemid 35285687)
31. Nozawa T, Nakajima M, Tamai I, et al. Genetic polymorphisms of human organic anion transporters OATP-C (SLC21A6) and OATP-B (SLC21A9): allele frequencies in the Japanese population and functional analysis. J Pharmacol Exp Ther. 2002;302(2):804-813 (Pubitemid 34787251)
32. Tirona RG, Leake BF, Merino G, Kim RB. Polymorphisms in OATP-C: identification of multiple allelic variants associated with altered transport activity among European-and African-Americans. J Biol Chem. 2001;276(38):35669- 35675 (Pubitemid 37384369)
33. Ho RH, Choi L, Lee W, et al. Effect of drug transporter genotypes on pravastatin disposition in European-and African-American participants. Pharmacogenet Genomics. 2007;17(8):647-656 (Pubitemid 47057714)
34. Ho RH, Tirona RG, Leake BF, et al. Drug and bile acid transporters in rosuvastatin hepatic uptake: function, expression, and pharmacogenetics. Gastroenterology. 2006;130(6):1793-1806
35. Sai K, Saeki M, Saito Y, et al. UGT1A1 haplotypes associated with reduced glucuronidation and increased serum bilirubin in irinotecan-administered Japanese patients with cancer. Clin Pharmacol Ther. 2004;75(6):501-515 (Pubitemid 38746601)
36. Newman TB, Xiong B, Gonzales VM, Escobar GJ. Prediction and prevention of extreme neonatal hyperbilirubinemia in a mature health maintenance organization. Arch Pediatr Adolesc Med. 2000;154(11):1140-1147 (Pubitemid 30828101)
37. Newman TB, Liljestrand P, Escobar GJ. Combining clinical risk factors with serum bilirubin levels to predict hyperbilirubinemia in newborns. Arch Pediatr Adolesc Med. 2005;159(2):113-119 (Pubitemid 40194175)
38. Keren R, Luan X, Friedman S, Saddlemire S, Cnaan A, Bhutani VK. A comparison of alternative risk-assessment strategies for predicting significant neonatal hyperbilirubinemia in term and near-term infants. Pediatrics. 2008;121(1). Available at: www.pediatrics.org/cgi/content/full/121/1/e170
39. Kaplan M, Herschel M, Hammerman C, Hoyer JD, Stevenson DK. Hyperbilirubinemia among African American, glucose-6-phosphate dehydrogenase-deficient neonates. Pediatrics. 2004;114(2). Available at: www.pediatrics.org/cgi/content/full/114/2/e213
40. Watchko JF. Identification of neonates at risk for hazardous hyperbilirubinemia: emerging clinical insights. Pediatr Clin North Am. 2009;56(3):671-687
41. Newman TB, Easterling J, Goldman ES, Stevenson DK. Laboratory evaluation of jaundice in newborns: frequency, cost and yield. Am J Dis Child. 1990;144(3):364-368 (Pubitemid 20067067)
42. Newman TB, Escobar GJ, Gonzales VM, Armstrong MA, Gardner MN, Folck BF. Frequency of neonatal bilirubin testing and hyperbilirubinemia in a large health maintenance organization. Pediatrics. 1999;104(5):1198-1203
43. Gale R, Seidman DS, Dollberg S, Stevenson DK. Epidemiology of neonatal jaundice in the Jerusalem population. J Pediatr Gastroenterol Nutr. 1990;10(1):82-86 (Pubitemid 20018113)
44. Khoury MJ, Calle EE, Joesoef RM. Recurrence risk of neonatal hyperbilirubinemia in siblings. Am J Dis Child. 1988;142(10):1065-1069
45. Stevenson DK, Fanaroff AA, Maisels MJ, et al. Prediction of hyperbilirubinemia in near-term and term infants. Pediatrics. 2001;108(1):31-39 (Pubitemid 32592002)
46. Maisels MJ, Kring E. The contribution of hemolysis to early jaundice in normal newborns. Pediatrics. 2006;118(1):276-279 (Pubitemid 46071172)
47. Bertini G, Dani C, Tronchin M, Rubaltelli FF. Is breastfeeding really favoring early neonatal jaundice? Pediatrics. 2001;107(3). Available at: www.pediatrics.org/cgi/content/full/107/3/ e41
48. Hirono A, Beutler E. Molecular cloning and nucleotide sequence of cDNA forhumanglucose-6-phosphate dehydrogenase variant A(-). Proc Natl Acad Sci U S A. 1988;85(11):3951-3954 (Pubitemid 18160645)
49. Vulliamy TJ, D'Urso M, Battistuzzi G, et al. Diverse point mutations in the human glucose-6-phosphate dehydrogenase gene cause enzyme deficiency and mild or severe hemolytic anemia. Proc Natl Acad Sci U S A. 1988;85(14):5171-5175 (Pubitemid 18192936)
50. Stevens DJ, Wanachiwanawin W, Mason PJ, Vulliamy TJ, Luzzatto L. G6PD Canton, a common deficient variant in South East Asia caused by a 459 Arg→Leu mutation. Nucleic Acids Res. 1990;18(23):7190
51. Chiu DT, Zuo L, Chen E, et al. Two commonly occurring nucleotide base substitutions in Chinese G6PD variants. Biochem Biophys Res Commun. 1991;180(2):988-993
52. Aono S, Yamada Y, Keino H, et al. Identification of defect in the genes for bilirubin UDP-glucuronosyl-transferase in a patient with Crigler-Najjar syndrome type II. Biochem Biophys Res Commun. 1993;197(3):1239-1244 (Pubitemid 124009574)
53. Koiwai O, Nishizawa M, Hasada K, et al. Gilbert's syndrome is caused by a heterozygous missense mutation in the gene for bilirubin UDP- glucuronosyltransferase. Hum Mol Genet. 1995;4(7):1183-1186
54. Kadakol A, Ghosh SS, Sappal BS, Sharma G, Chowdhury JR, Chowdhury NR. Genetic lesions of bilirubin uridine-diphosphoglucuronate glucuronosyltransferase (UGT1A1) causing Crigler-Najjar and Gilbert syndromes: correlation of genotype to phenotype. Hum Mutat. 2000;16(4):297-306 (Pubitemid 30740441)
55. Sugatani J, Yamakawa K, Yoshinari K, et al. Identification of a defect in the UGT1A1 gene promoter and its association with hyperbilirubinemia. Biochem Biophys Res Commun. 2002;292(2):492-497 (Pubitemid 34694291)
56. 7TAA allele in India and its interaction with a novel CAT insertion in promoter of the gene for bilirubin UDP- glucuronosyltransferase 1 gene. World J Gastroenterol. 2006;12(14):2269-2275
57. Nishizato Y, Ieiri I, Suzuki H, et al. Polymorphisms of OATP-C (SLC21A6) and OAT3 (SLC22A8) genes: consequences for pravastatin pharmacokinetics. Clin Pharmacol Ther. 2003;73(6):554-565 (Pubitemid 37249126)